Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors

Front Med (Lausanne). 2023 Jan 4:9:1116908. doi: 10.3389/fmed.2022.1116908. eCollection 2022.

Authors

Beatrice Aramini¹, Valentina Masciale²

Affiliations

¹ Division of Thoracic Surgery, Department of Experimental, Diagnostic and Specialty Medicine-DIMES of the Alma Mater Studiorum, University of Bologna, G.B. Morgagni-L. Pierantoni Hospital, Forlí, Italy.
² Division of Oncology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.

No abstract available

Keywords: NSCLC; aldehyde dehydrogenase (ALDH); cancer stem cell (CSC); nanoparticle; recurrence.

Publication types

Editorial